Hartley
As advances in molecular science develop rapidly in laboratories, legal observers wonder if toxicogenomics will provide the next holy grail for toxic tort litigation -- specific causation.
Andrew Klein, professor of law at Indiana University School of Law, has written that "elucidation of the human genome makes it conceivable that scientists soon will link genetic change to specific exposures, and ultimately clinical disease in a way that used to be unimaginable."
Read more ...